The Full Wiki

More info on LY-487,379

LY-487,379: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

Systematic (IUPAC) name
N-(4-(2-methoxyphenoxy)phenyl)- N-(2,2,2-trifluoroethylsulfonyl)pyrid- 3-ylmethylamine
CAS number  ?
ATC code  ?
PubChem 9825084
Chemical data
Formula C 21H19F3N2O4S 
Mol. mass 452.446 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

LY-487,379 is a drug used in scientific research that acts as a selective positive allosteric modulator for the metabotropic glutamate receptor group II subtype mGluR2.[1] It is used to study the structure and function of this receptor subtype,[2][3] and LY-487,379 along with various other mGluR2/3 agonists and positive modulators are being investigated as possible antipsychotic and anxiolytic drugs.[4][5][6][7]

See also


  1. ^ Johnson, M. P.; Baez, M.; Jagdmann Jr, G. E.; Britton, T. C.; Large, T. H.; Callagaro, D. O.; Tizzano, J. P.; Monn, J. A. et al. (2003). "Discovery of Allosteric Potentiators for the Metabotropic Glutamate 2 Receptor:  Synthesis and Subtype Selectivity ofN-(4-(2-Methoxyphenoxy)phenyl)-N-(2,2,2− trifluoroethylsulfonyl)pyrid-3-ylmethylamine". Journal of Medicinal Chemistry 46 (15): 3189–3192. doi:10.1021/jm034015u. PMID 12852748.   edit
  2. ^ Schaffhauser, H.; Rowe, B. A.; Morales, S.; Chavez-noriega, L. E.; Yin, R.; Jachec, C.; Rao, S. P.; Bain, G. et al. (2003). "Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2". Molecular Pharmacology 64 (4): 798. doi:10.1124/mol.64.4.798. PMID 14500736.  
  3. ^ Poisik, O. (2005). "Metabotropic glutamate receptor 2 modulates excitatory synaptic transmission in the rat globus pallidus". Neuropharmacology 49: 57–50. doi:10.1016/j.neuropharm.2005.03.006.  
  4. ^ Galici, R.; Echemendia, N. G.; Rodriguez, A. L.; Conn, P. J. (2005). "A Selective Allosteric Potentiator of Metabotropic Glutamate (mGlu) 2 Receptors Has Effects Similar to an Orthosteric mGlu2/3 Receptor Agonist in Mouse Models Predictive of Antipsychotic Activity". Journal of Pharmacology and Experimental Therapeutics 315: 1181. doi:10.1124/jpet.105.091074.  
  5. ^ Marino; Conn, P. (2006). "Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors". Current opinion in pharmacology 6 (1): 98–102. doi:10.1016/j.coph.2005.09.006. PMID 16368268.   edit
  6. ^ Harich; Gross, G.; Bespalov, A. (2007). "Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment". Psychopharmacology 192 (4): 511–519. doi:10.1007/s00213-007-0742-y. PMID 17318501.   edit
  7. ^ PMID 190790739 (PubMed)
    Citation will be completed automatically in a few minutes. Jump the queue or expand by hand


Got something to say? Make a comment.
Your name
Your email address